BR9916021A - Composições farmacêuticas contendo quinaprilmagnésio - Google Patents

Composições farmacêuticas contendo quinaprilmagnésio

Info

Publication number
BR9916021A
BR9916021A BR9916021-8A BR9916021A BR9916021A BR 9916021 A BR9916021 A BR 9916021A BR 9916021 A BR9916021 A BR 9916021A BR 9916021 A BR9916021 A BR 9916021A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
quinapril
quinaprilmagnesium
compositions containing
magnesium
Prior art date
Application number
BR9916021-8A
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19927062&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9916021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Publication of BR9916021A publication Critical patent/BR9916021A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS CONTENDO QUINAPRILMAGNéSIO". Composições sólidas estáveis contendo quinaprilmagnésio podem ser fabricadas usando o quinapril ou um sal deadição ácida dele proveniente, mediante a reação do quinapril oudo sal de adição ácida dele proveniente com um composto alcalinode magnésio em presença de um solvente, de modo a convertertodo ou substancialmente todo o quinapril ou o sal de adição ácidaao quinapril magnésio.
BR9916021-8A 1998-12-08 1999-12-07 Composições farmacêuticas contendo quinaprilmagnésio BR9916021A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ333206A NZ333206A (en) 1998-12-08 1998-12-08 Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
PCT/CA1999/001169 WO2000034314A1 (en) 1998-12-08 1999-12-07 Pharmaceutical compositions comprising quinapril magnesium

Publications (1)

Publication Number Publication Date
BR9916021A true BR9916021A (pt) 2001-10-30

Family

ID=19927062

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916021-8A BR9916021A (pt) 1998-12-08 1999-12-07 Composições farmacêuticas contendo quinaprilmagnésio

Country Status (15)

Country Link
US (1) US6531486B1 (pt)
EP (1) EP1137662B1 (pt)
JP (1) JP5296277B2 (pt)
KR (1) KR20010080718A (pt)
AT (1) ATE275577T1 (pt)
AU (1) AU759889B2 (pt)
BR (1) BR9916021A (pt)
CA (1) CA2355347C (pt)
CZ (1) CZ20012013A3 (pt)
DE (1) DE69920039T2 (pt)
ES (1) ES2229793T3 (pt)
IL (1) IL143652A0 (pt)
NZ (1) NZ333206A (pt)
WO (1) WO2000034314A1 (pt)
ZA (1) ZA200104614B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3727848B2 (ja) * 1998-06-05 2005-12-21 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 酸化マグネシウムを使用する、ａｃｅ阻害剤を含有する組成物の安定化
US20030027837A1 (en) * 1998-12-08 2003-02-06 Sherman Bernard Charles Pharmaceutical compositions comprising quinapril magnesium
CA2357982A1 (en) * 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
WO2005027881A2 (en) * 2003-09-23 2005-03-31 Texcontor Etablissement Stable quinapril compositions
GB201017808D0 (en) 2010-10-21 2010-12-01 Univ Salford The An air spring
GB201405647D0 (en) 2014-03-28 2014-05-14 Carbon Air Ltd Transfer method and apparatus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4830853A (en) 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
SI9111842A (sl) 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
JP3727848B2 (ja) * 1998-06-05 2005-12-21 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 酸化マグネシウムを使用する、ａｃｅ阻害剤を含有する組成物の安定化

Also Published As

Publication number Publication date
CA2355347A1 (en) 2000-06-15
ATE275577T1 (de) 2004-09-15
AU1542200A (en) 2000-06-26
ZA200104614B (en) 2002-06-26
AU759889B2 (en) 2003-05-01
ES2229793T3 (es) 2005-04-16
JP5296277B2 (ja) 2013-09-25
NZ333206A (en) 2000-07-28
EP1137662B1 (en) 2004-09-08
DE69920039D1 (de) 2004-10-14
CA2355347C (en) 2011-06-21
CZ20012013A3 (cs) 2001-10-17
DE69920039T2 (de) 2005-09-22
JP2002531577A (ja) 2002-09-24
US6531486B1 (en) 2003-03-11
EP1137662A1 (en) 2001-10-04
IL143652A0 (en) 2002-04-21
WO2000034314A1 (en) 2000-06-15
KR20010080718A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
JPS5353642A (en) Preparation of alpha,alpha-dimethylbenzyl-isocyanate or its nuclear-substituted derivatives
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
ATE242183T1 (de) Glaszusammensetzung zur vermeidung der alkali- kiesel-kieselsäure reaktion
BR9916021A (pt) Composições farmacêuticas contendo quinaprilmagnésio
JPS543087A (en) Preparation of cephalosporin compound
ATE464043T1 (de) Pharmazeutische zusammensetzung enthaltend l- arginin
BRPI0410602A (pt) formulações de barreira ao oxigênio
EA200100947A1 (ru) Жевательные таблетки с высоким содержанием n-ацетилцистеина
SE9903290D0 (sv) Novel compounds
NO20030182D0 (no) Dermalt påföringssystem for aminolevulinsyre
DE60127019D1 (de) Moexipril-Magnesium enthaltende Arzneimittel
JPS535180A (en) Preparation of 3,4-dihydro-2 (1h) quinazoline derivatives
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
ATE192749T1 (de) Wässrige spectinomycinborat-auflösung
KR920002740A (ko) 토양 경화제
JPS53119820A (en) Preparation of alkali aminodiacetate
RU2000118069A (ru) Добавка в бетонную смесь
JPS53121787A (en) Preparation of oxazolinoazetidinylpentenoic acid derivatives
AU9694298A (en) Synthesis of 3-carbomethoxy-4,5-dimethylthiophene
GB1399561A (en) Compounds derived from dioxabicyclooctane-diones and the preparation thereof
GEP20084394B (en) Novel intermediate for the preparation of therapeutically active imidazopyridines
RU2002117869A (ru) Тампонажный состав для изоляции проницаемых пластов
JPS53101323A (en) Preparation of 2-substd-2-sulfenyl-1,3-dicarbonyl copound
JPS537688A (en) Preparation of n1-(2-tetrahydrofuranyl)-5-fluorouracil

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5O, 6O E 7O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.